Page 987 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 987

CHaPTEr 70  Autoimmune Thyroid Diseases                 953


           and orbital pressure is relieved by urgent orbital decompression   effect. These data highlight the need to further investigate the
           surgery. In patients whose eyelids do not close completely, eye   MHC region to clarify its role in AH susceptibility.
           ointments and protective eye pads are essential to protect the   In common with GD, the CTLA-4 gene also appears to influ­
           eyes against corneal damage and ulceration. Once disease activity   ence AH susceptibility. Three CTLA-4 polymorphisms have been
           has burned out, rehabilitative surgery can greatly improve the   associated with AH in a number of populations. An A/G SNP
           function and cosmetic appearance of the eyes. Orbital decompres­  located downstream of the 3’UTR (designated CT60), an A/G
           sion, strabismus correction, and eyelid surgery are commonly   polymorphism at codon 17, and a 106­bp microsatellite repeat
           used procedures. 22                                    in the 3’UTR of exon 3. A locus on chromosome 8q24 containing
                                                                  the thyroglobulin gene was linked to AH, and a number of SNPs
           FUTURE DEVELOPMENTS FOR GRAVES                         were subsequently studied in AH individuals with modest reported
           HYPERTHYROIDISM AND OPHTHALMOPATHY                     ORs for association of between 1.32 and 1.56. Other loci impli­
                                                                  cated in  AH susceptibility include the tumor necrosis factor
           Novel approaches to modulating the immune response in GD   (TNF-α) gene, PTPN22, CYP27B1, T­cell receptor (TCR) genes,
           and GO as a therapeutic strategy are under investigation. In light   and several immunoglobulin genes and cytokine regulatory genes.
           of the significant side effects associated with steroid therapy   In contrast to GD, environmental factors in AH susceptibility
           for GO, steroid­sparing agents, including methotrexate and   have been challenging to identify. However, the role of iodine is
           mycophenolate mofetil, are of particular interest. Novel biological   widely accepted, since population studies have reported an increase
           agents have been evaluated to a limited extent in these condi­  in the prevalence of thyroid lymphocytic infiltration and auto­
                                                  23
           tions and are subject to further ongoing studies.  Rituximab,   antibodies following public health salt iodization programs.
           a CD20 monoclonal antibody (mAb) that depletes circulating   Infectious agents have also been implicated in susceptibility to
           B cells, appeared to be potentially efficacious in early studies;   AH. Several studies have identified an increased prevalence of
           however, in two randomized controlled trials in individuals with   IgG and/or IgA antibodies to virulence­associated outer mem­
           moderate to severe active GO, results have been conflicting, and   brane proteins of Yersinia enterocolitica in AH patients and in
           therefore further studies are now needed. A longer­term goal is   relatives of individuals with AH, suggesting that susceptibility
           the development of an anti–TSH­R antibody or small molecule   genes for Yersinia infection may also confer risk for AH.
           antagonist that could block binding of stimulatory TSH­R anti­  The effect of radiation, either “internal” (nuclear “fallout” or
           bodies or inhibit TSH­R signaling, thus ameliorating the cause of    from  RAI  treatment)  or  “external”  (radiotherapy  or  direct
           hyperthyroidism.                                       exposure during a nuclear accident), on AH susceptibility has
                                                                  been extensively studied. Following the nuclear reactor accident
           AUTOIMMUNE HYPOTHYROIDISM                              at Chernobyl, a rise in thyroid autoantibodies was noted 15 years
                                                                  following exposure; however, this was not accompanied by thyroid
                                                                            25
           The most common cause of autoimmune hypothyroidism (AH)   dysfunction.  Long­term follow­up studies of thyroid function
           is chronic (or lymphocytic) autoimmune thyroiditis. There are   in Japanese survivors of the atomic bombing of Nagasaki and
           two variants, atrophic and goitrous (Hashimoto thyroiditis).  Hiroshima have demonstrated a clear link between radiation
                                                                  exposure and thyroid cancer; however, the association with AH
           Epidemiology                                           remains disputed. One study, at 40 years follow­up, demonstrated
           In populations living in iodine sufficient areas, AH is common,   a significant relationship between dose of radiation exposure at
           affecting between 1 and 10% of the population. The prevalence   Nagasaki and AH. However, a further study, at more than 50
           increases with age, with 3–20% of individuals over 75 years of   years of follow­up, showed that radiation exposure did not
           age being hypothyroid. Like GD, AH is more common in women   correlate with either the occurrence of thyroid autoantibodies
           than in men. In a UK community survey, the incidence of   or AH. 26
           hypothyroidism in women was 3.5/1000/year, which increased
           to 13.7/1000/year in women between 75 and 80 years of age. In   Immunopathogenesis
           men, the incidence was just 0.6/1000/year. 24          The mechanisms by which tolerance to thyroid antigens is
                                                                  lost in the first instance remain obscure. It appears that both
           Etiology                                               a susceptible genetic background and a permissive environ­
           AH, like GD, is a complex genetic condition. Familial clustering   ment are required before AH develops. Notably, AH is much
           provides evidence for a genetic etiology, which, in several studies,   more frequent in the autoimmune polyendocrinopathy type 1
           appears stronger than that for GD. The λs for AH is estimated   (APECED) syndrome than GD, suggesting that central thymic
           to be between 10 and 45, suggesting that AH is more heritable   T­cell selection, and therefore central tolerance, may be more
           compared with GD. In families with autoimmunity, frequently   important in  AH than in GD. Histologically, lymphocytic
           a mixture of individuals affected by AH and GD are seen, sug­  infiltrates can be seen in the thyroid, consisting of both T and
           gesting some shared genetic factors. The differing prevalence of   B cells (Fig. 70.7). These infiltrates can be diffuse or focal.
           AH in different ethnic groups, with AH being more common   Scarring and fibrosis may also be seen, with destruction of the
           in Caucasian than in black populations, also supports a genetic   normal thyroid architecture and an absence of colloid in thyroid
           background. Knowledge about the genetics of AH is limited.  follicles.
             The MHC class II HLA-DR3, ­DR4, and ­DR5 alleles have   Both cell­mediated and humoral immune mechanisms are
           been associated with AH in Caucasians only. Conflicting results   important in the continuing thyroid damage seen in AH. T cells
           have been reported for HLA-DQ alleles. One study reported that   are known to play a pivotal role in both the initiation and perpetu­
           the HLA-DQ alleles DQA1*0301 and DQB1*0201 confer sus­  ation of AH. Studies in which researchers induced hypothyroidism
           ceptibility to AH in Caucasians, with certain HLA-DQ alleles   in Rag1­deficient transgenic mice that were unable to produce
                                                                                       27
           (DQA1*0102 and DQB1*0602) reported to confer a protective   autoantibodies confirm this.  T cells respond to antigen­presenting
   982   983   984   985   986   987   988   989   990   991   992